Constellation Energy Corp. reports fourth-quarter results Thursday, with analysts expecting a sharp sequential decline as the nation’s largest nuclear power operator works to integrate its massive ...
Analysts expect Insulet to post earnings per share of $1.46 on revenue of $768.59 million, representing year-over-year growth ...
1d
Halozyme outlines $1.71B–$1.81B 2026 revenue target as new subcutaneous technologies expand pipeline
Current quarter guidance for 2026 total revenue of $1.71 billion to $1.81 billion and non-GAAP diluted EPS of $7.75 to $8.25 marks a substantial increase from the previous quarter's guidance of $1.3 ...
Matt Moschner: 2025 marked a return to profitable growth for Cognex Corporation. This includes the divestment of a ...
Canadian stocks outperformed US peers last year, but could that continue as investors re-assess potential impact of AI and trade tensions? TD Asset Management's Michael O’Brien discusses.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 2026 10x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19. Operator: Thank you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results